Friday, 17 Aug 2018

You are here

The RheumNow Week in Review - 2 March 2018

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com.

  1. FDG-PET Scans in large vessel vasculitis (eg, Takayasus) capable to detecting active disease with 85% sensitivity and 83% specificity. Abnormal PET during remission, predicts 5 fold high risk of relapse. https://t.co/r2r2oCk0Kj
  2. Viscosupplementation of the hip joint DOES NOT WORK in numerous RTCs - with little/no evidence of efficacy at 3 and 6 months. https://t.co/rOk9JJ8uYI
  3. Curcumin combined with boswellic acid shown to be effective in 201 osteoarthritis patients in a randomized, double-blind, placebo-controlled study. https://t.co/Mlai1P7Yww
  4. Anti-mitochondrial antibodies found with inflammatory myositis may be associated with severe cardiac involvement. 4/7 had necrotizing myopathy and 3/7 had other autoimmune Dz - PBC, autoimmune hepatitis, Psoriasis, Hashimoto’s https://t.co/bssYfmQXfl
  5. A substudy within the BeST study found that TNF inhibitor Rx associated with less Xray development of OA in DIP (but not PIP) joints - 2.3% less for every month of TNFi Rx. https://t.co/zh8WD2DUcW
  6. Of 134 RTX treated pts (mean 79 mos), 23 (17%) developed Hypogammaglobulinemia after a mean 64 mos & assoc w/ 4x risk of severe infections. Gammaglobulin <8 g/L at baseline was a predictor of hypogamma (HR 7.34), but MTX was protective (HR 0.26)    https://t.co/AMOtNAUeXR
  7. Hip Replacement Augments Longevity  http://rheumnow.com/content/hip-replacement-augments-longevity 
  8. Gout Crystal Deposition is Deeper than its Measures    http://rheumnow.com/content/gout-crystal-deposition-deeper-its-measures
  9. Probenecid Benefits Heart Failure   http://rheumnow.com/content/probenecid-benefits-heart-failure
  10. IL-18 Binding Protein Effective in Adult-Onset Still's Disease  http://rheumnow.com/content/il-18-binding-protein-effective-adult-onset-...

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

ACR Meets With HHS Secretary Azar to Discuss Step Therapy Concerns

Yesterday, the American College of Rheumatology (ACR) met with U.S. Department of Health and Human Services Secretary Alex Azar for a productive discussion about the rheumatology community's concerns with a new policy that will allow Medicare Advantage plans to utilize step therapy in Medicare Part B. In the meeting, the ACR expressed concerns that this policy would delay rheumatology patients' access to treatments.

The RheumNow Week in Review – We’re Number One! (8.17.18)

Dr. Cush reviews the articles and news from the last week on RheumNow.com. Information on comorbidities, the downside of steroids, unmet need in psoriatic arthritis, and the top 10 rheumatology programs.

U.S. News 2018-19 Rheumatology Rankings

The Annual U.S. News and World Report Rankings of Hospitals has listed the top contenders in the field of rheumatology. The U.S. News Review rates hospitals nationwide in 16 specialties – including rheumatology. Of the 4,500 hospitals covered by U.S. News that were analyzed, 158 were classified nationally in at least one specialty area.

The RheumNow Week in Review – No Good Gout (8.10.18)

Dr. Jack Cush reviews the news and latest journal articles from the past week on RheumNow.com. Info on Surgery and Hip Fractures, Gout drugs abandoned, Allopurinol escalation, hydroxychloroquine drug levels, how to treat scleroderma in India and exactly who gets back pain.

The RheumNow Week in Review – Handshakes or Hugs (8.3.18)

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com, including new treatments for LTBI, gout consequences, RA and offspring risk, PsA risk, and the opioid epidemic effects.